Article · 29 Aug 2026
Conference abstract
In vivo electroporation for improvement of therapeutic DNA vaccine against chronic hepatitis B infection
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
D espite the existence of an effective prophylactic vaccine, chronic hepatitis B virus (HBV) infection remains a major public health problem. DNA-based vaccination has emerged as promising immunotherapeutic approach against chronic hepatitis B, although its efficacy needs to be increased as indicated by the results of first clinical trials. In this regard in vivo electroporation (EP)-mediated delivery appears of particular interest to improve therapeutic potency of DNA vaccines against chronic viral diseases. However, little was known of the ability of EP to improve DNA vaccine for therapy of chronic hepatitis B infection. We explored EP-mediated DNA vaccine delivery for hepatitis B immunotherapy using the duck HBV (DHBV) infection model, which is a reference for novel anti-HBV approaches evaluation. We first demonstrated in na?ve animals that EP was able to dramatically enhance neutralizing potency of DNA vaccine leading to highly neutralizing, multi-specific B-cell response at clinically feasible DNA dose. Next, the therapeutic benefit of EP-mediated DNA vaccine delivery was investigated. The therapy of chronic DHBV-carrier ducks with EP-delivered DNA vaccine encoding viral proteins (envelope, core) and IFN- γ resulted in a marked and sustained decrease in viremia titers as compared with standard needle DNA injection. Importantly, a significant decrease in intrahepatic covalently closed circular viral DNA (cccDNA) form, responsible for chronicity of infection, was observed following EP of DNA vaccine. In addition a break of immune-tolerance was observed after DNA vaccine administration by EP. Collectively, our data indicate that electroporation is able to dramatically enhance therapeutic potency of DNA vaccine targeting hepadnaviral proteins supporting clinical application of this approach against chronic hepatitis B.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Lucyna Cova”